Background. Metabolic disorders are prevalent in women with breast cancer and breast cancer survivors. Such disorders increase breast cancer mortality and likelihood of relapse 2-and 3-fold, respectively. However, there is a severe lack of research into the physiological sequelae of breast cancer, including the metabolic health consequences. The aim of the present study was to provide novel insights into the causes of metabolic disturbances associated with breast cancer by investigating the effects of breast cancer on insulin sensitivity in skeletal muscle.
(ECL+; Amersham Biosciences). Coomassie staining was used as a loading control. Amount of protein loaded = 3 µg.
Statistical analyses. Results are shown as individual values with mean ± SEM. Statistical significance was tested using unpaired t-test or two-way ANOVA, as appropriate. If the null hypothesis was rejected, Tukey's post hoc test was used to evaluate main effects and significant interactions in ANOVAs. The significance level was set at p-values <0.05. Statistical analyses were performed using Graph Pad PRISM v.6.01 software (GraphPad Software, Inc., San Diego, CA).
Results

Conditioned media from breast cancer cells reduced GLUT4 translocation in L6 myotubes.
Conditioned media (CM) from MCF7 and BT474 cells contain a large accumulation of secreted proteins that is unique to each cell line [34] . We used breast cancer CM to address whether secreted tumorkines in breast cancer might directly affect skeletal muscle insulin responsiveness. L6 myotubes stably expressing a GLUT4myc epitope were incubated with 25% CM from MCF7 or BT474 breast cancer cells for 72 hours, and basal-and insulin-stimulated GLUT4 translocation was measured. CM from MCF7 significantly reduced both basal (-10%) and insulin (-14%) -stimulated GLUT4 translocation in L6 myotubes compared to the control media incubated L6 myotubes (Fig.   1A ). The fold-change in response to insulin was also reduced (-13%), indicating a reduced insulin responsiveness of myotubes exposed to CM from MCF7 breast cancer cells ( Fig. 1B) . BT474 cell CM also reduced basal (-16%) and insulin (-8%) -stimulated GLUT4 translocation in L6 myotubes compared to the control media incubated L6 myotubes (Fig. 1C ). However, the fold-change in response to insulin was actually increased by CM from BT474 (+9%), indicative of an increased insulin responsiveness (Fig. 1D ), despite the generally lower GLUT4 translocation. These findings show that GLUT4 translocation in skeletal muscle cells are significantly affected by breast cancer derived factors, as both MCF7 and BT474 CM reduced basal-and insulin-stimulated GLUT4 translocation.
Insulin-stimulated 2DG glucose uptake is reduced in L6 myotubes incubated with MCF7 and BT474 conditioned media. Recently, we reported that the presence of cancer in mice significantly reduced insulin-stimulated glucose uptake in mouse skeletal muscle [22] . Therefore, we next investigated the effect of MCF7 and BT474 CM on insulin-stimulated glucose uptake in L6 myotubes. Because we detected differences in absolute uptake rates between experimental days, we have shown the results for each individual experiment. MCF7 and BT474 CM did not affect L6 myotube glucose uptake during basal state (Fig. 2A+B ). We observed a mild, yet significant reduction in insulin-stimulated glucose uptake in L6 myotubes incubated with MCF7 (-6%) and BT474 (-15%) CM ( Fig. 2C+D ) compared to the control condition. These results suggest that cancer can directly reduce insulin sensitivity in L6 myotubes.
Breast cancer conditioned media influences intramyocellular insulin signaling. We next investigated the intracellular insulin signaling in L6 myotubes incubated with MCF7 or BT474 CM to elucidate if intracellular signaling defects were causing the reduced insulin response on GLUT4 translocation and glucose uptake. Thus, we analyzed the phosphorylation (p) of Akt Ser473 , Akt Thr308 , and TBC1D4 Thr642 by immunoblotting techniques. p-Akt Thr308 tended to be reduced (-34%, p=0.08) with incubation of MCF7 CM compared to the controls (Fig. 3A) , while p-Akt ser473 was unaltered ( Fig. 3B) . Surprisingly, given the normal or reduced p-Akt, GLUT4 translocation, and 2DG uptake, insulin-stimulated p-TBC1D4 Thr642 was increased (+34%) in L6 myotubes incubated with MCF7 CM. L6 myotubes incubated with BT474 CM also tended to have reduced (-37%, p=0.098) insulinstimulated p-Akt Thr308 (Fig. 3D ) but normal p-Akt ser473 (Fig. 3E ) and p-TBC1D4 Thr642 (Fig. 3F ). The protein expression of Akt2 and TBC1D4 were not affected by incubating L6 myotubes with MCF7 or BT474 CM ( Fig. 3G+H ). Representative blots are shown in Fig. 3I . Taken together, these results suggest that breast cancer cells can directly influence intracellular insulin signaling in muscle without altering protein expression of Akt2 or TBC1D4.
Discussion.
The current study demonstrates that media from breast cancer cells markedly influences insulin responsiveness in skeletal muscle myotubes. This was evidenced on three parameters, i) reduced basal-and insulin-stimulated GLUT4 translocation, ii) impaired insulin-stimulated glucose uptake, and iii) altered intramyocellular insulin signaling. To our knowledge, these findings are the first to suggest that breast cancer might directly rewire skeletal muscle cells rendering them insulin resistant. Our findings are in agreement with a growing number of studies that report that breast cancer survivors experience significant metabolic dysregulations, including hyperglycemia and hyperinsulinemia, which could be caused by skeletal muscle insulin resistance [13, 18] .
The physiology of insulin resistance induced by cancer is fascinating; from a cancer point of view designed to limit the host´s glucose uptake and thereby shunt an adequate amount of supply to the growing cancer cells. However, in breast cancer, the underlying mechanisms causing such metabolic perturbations is undescribed. Our results suggest that breast cancer cells might influence skeletal muscle rendering them insulin resistant and we speculate that this could contribute to the metabolic perturbations observed in up to 80% of breast cancer patients and survivors [4] [5] [6] 11] .
Breast cancer is subdivided into several different subtypes based on their gene expression pattern [23] [24] [25] . Each breast cancer subtype develops, metastasizes, and responds to therapy differently and also interacts with the surrounding environment differently [35] . Indeed, CM of breast cancer cell lines from different subtypes have shown to contain a large accumulation of secreted proteins that are unique to every cell line [34, 36] . We used CM of MCF7 (luminal A), BT474 (luminal B) to investigate the insulin responsiveness of L6 muscle cells. CM from both breast cancer cell lines reduced basal and insulin-stimulated GLUT4 translocation and impaired glucose uptake. For both MCF7 and BT474 CM, this was accompanied by a tendency to reduced p-Akt Thr308 (but not Ser473), while only MCF7 altered p-TBC1D4 Thr642 . That only MCF7 influenced the latter, could indicate distinct interaction with its microenvironment compared to the BT474 breast cancer cell line.
We did not identify the factor(s) secreted by breast cancer cells that could induce insulin resistance in muscle. However, other studies have analyzed breast cancer secreted media from BT474 and found more than 1.100 secreted proteins [34, 36] . Another study analyzed the secretomes in CM from breast cancer cells including MCF7 [36] . They identified four biomarkers in the CM that were also found in plasma from breast cancer patients including GM2A and IGFBP using Mass Spectrometry [36] . Elevated levels of GM2A has shown implication in insulin resistant conditions [37] , whereas IGFBP overexpressing mice have shown impaired glucose homeostasis and hyperinsulinemia [38] . However, future studies should investigate breast cancer cell-secreted factors involved in induction of muscle insulin resistance.
That breast cancer rewires the muscles and fat, is supported by a preliminary study revealing that skeletal muscles of women with newly diagnosed breast cancer undergo significant molecular changes. Of these, the most significant changes were precisely for proteins involved in metabolic regulation [39] , although no functional outcome of these changes were investigated. Thus, our present in vitro findings align with in vivo results from humans showing significant molecular rewiring of skeletal muscle in patients with breast cancer. Our study provides mechanistic evidence that might explain why women who develop breast cancer have a higher incidence of metabolic dysfunctions, such as for example diabetes, than women who do not develop breast cancer [39, 40] .
Other cancer cell types might also induce muscle insulin resistance, as other cancers have been associated with impaired metabolic regulation. In fact, it has been reported that one-third of cancer patients present diabetic glucose tolerance curves [41] . For example, colorectal cancer is associated with increased risk of developing diabetes within five years after the diagnosis [42] . Additionally, a study from our group has recently shown that Lewis lung cancer implanted into immunocompetent mice caused metabolic perturbations on at least six metabolically essential functions; i) insulin's blood-glucose-lowering effect, ii) glucose tolerance, iii) skeletal muscle and white adipose tissue insulin-stimulated glucose uptake, iv) intramyocellular insulin signaling, v) muscle microvascular perfusion, and vi) basal hepatic glucose production [22] . Such studies suggest that metabolic regulation is disturbed in several cancers.
As 60-80% of women with breast cancer develop metabolic disorders during or following their treatment [4] [5] [6] , enhancing muscle insulin sensitivity could be a powerful means to improve metabolic regulation for these women. Accordingly, exercise training, which is the most effective means to improve skeletal muscle insulin sensitivity [15] , can completely prevent metabolic disturbances in breast cancer survivors [4] . This would have real clinical benefits, as metabolic dysregulation is associated with 3-fold increase likelihood of breast cancer returning [7, 8] .
Accordingly, exercise training is associated with reduced risk of breast cancer and breast cancer recurrence [43] [44] [45] [46] . Thus, exercise, diet, or other medical intervention to prevent or control insulin resistance should likely be considered as standard breast cancer care.
Conclusion.
In conclusion, breast cancer conditioned media significantly impaired the insulin responsiveness in L6 skeletal muscle cells. Thus, our study provide evidence to suggest that breast cancer cells can directly induce skeletal muscle insulin resistance. Given skeletal muscles key role in metabolic regulation, breast cancer-induced skeletal muscle insulin resistance might be an underlying cause of metabolic dysregulation observed in the majority of breast cancer patients and survivors. 
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